Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NX-1207 for LUTS Associated with BPH
NCT02003742Phase 3Terminated
- Sponsor
- Recordati SpA
- Start
- Sep 2013
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of REC 0482 in benign prostatic hyperplasia (BPH), sponsored by Recordati SpA. Started Sep 2013; status: terminated.
02
Drugs
REC 0482
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02003742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02003742.